Matching slides 303,780
Current window 202,171-202,200
Pages 10,126
Rows per page 30
Component: Titleclear collectionreset all

Component

202,171-202,200 of 303,780

filter-aware
55
The slide contains four dose-response curves (a-d) and two box-and-whisker plots (e-f) showing cytokine levels in patient biopsies.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
56
The slide outlines a drug discovery pipeline starting from a biological question, moving through computational target identification, and ending with experimental validation.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
57
The slide uses a combination of a biological pathway diagram, scatter plots for differential expression, and a line chart for tissue-specific expression.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
58
The slide uses a process diagram to explain the experimental setup and bar charts to show the efficacy of the compound in reducing IL-6 and IL-8 levels.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
59
The slide uses a causal flow diagram to link PDE10 inhibition to therapeutic outcomes in IBD.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
60
The slide uses a combination of a horizontal timeline graphic and three vertical columns detailing specific development phases.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
61
BenevolentAI | Investor Day Presentation Deck | 74 slidesBenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
62
The chart uses a Gantt-like structure to represent drug development stages (Target ID to Phase III).BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
63
The slide uses a process flow diagram to illustrate the integration of AI-driven precision medicine into the standard pharmaceutical R&D lifecycle.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
64
BenevolentAI | Investor Day Presentation Deck | 74 slidesBenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
65
BenevolentAI | Investor Day Presentation Deck | 74 slidesBenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
66
BenevolentAI | Investor Day Presentation Deck | 74 slidesBenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
67
The table shows financial results for the six months ended 30 June 2022 vs 2021. Expenses are shown in parentheses indicating negative values.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
68
The slide explains the impact of non-recurring business combination costs on the operating loss.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
69
The slide reconciles operating loss to cash expended from underlying operating activities and shows the movement in cash balance.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
70
The slide uses a hub-and-spoke diagram to link the company to five specific capital allocation priorities.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
71
BenevolentAI | Investor Day Presentation Deck | 74 slidesBenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
72
BenevolentAI | Investor Day Presentation Deck | 74 slidesBenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
73
BenevolentAI | Investor Day Presentation Deck | 74 slidesBenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
74
BenevolentAI | Investor Day Presentation Deck | 74 slidesBenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
02
BMO Capital Markets | Investment Banking Pitch Book | 22 slidesBMO Capital Markets | Investment Banking Pitch Book | 22 slides · BMO Capital Markets
Consulting deck Investment bank Beat · Situation & Context1 hit
03
The slide compares the Turquoise Hill benchmark against the Rio Tinto proposal across various financial and structural dimensions.BMO Capital Markets | Investment Banking Pitch Book | 22 slides · BMO Capital Markets
Consulting deck Investment bank Beat · Situation & ContextLoop · Pattern Hunter1 hit
04
The chart illustrates the market reaction to the Rio Tinto offer, showing the initial premium and the current premium relative to the peer group index.BMO Capital Markets | Investment Banking Pitch Book | 22 slides · BMO Capital Markets
Consulting deck Investment bank Beat · Situation & ContextLoop · Pattern Hunter1 hit
05
Includes production volume, cost curve, and country risk premium data.BMO Capital Markets | Investment Banking Pitch Book | 22 slides · BMO Capital Markets
Consulting deck Investment bank Beat · Situation & ContextLoop · Pattern Hunter1 hit
06
The chart uses a stacked bar format for later years to distinguish between GoM dividends and TRQ cash flows.BMO Capital Markets | Investment Banking Pitch Book | 22 slides · BMO Capital Markets
Consulting deck Investment bank Beat · Evidence & ProofLoop · Pattern Hunter1 hit
07
Includes median lines for Developer and Producer transactions.BMO Capital Markets | Investment Banking Pitch Book | 22 slides · BMO Capital Markets
Consulting deck Investment bank Beat · Evidence & ProofLoop · Pattern Hunter1 hit
08
The chart highlights specific transaction data points with a focus on Rio Tinto/Turquoise Hill.BMO Capital Markets | Investment Banking Pitch Book | 22 slides · BMO Capital Markets
Consulting deck Investment bank Beat · Evidence & ProofLoop · Pattern Hunter1 hit
09
The chart overlays transaction events (producers vs developers) onto a historical copper price time series.BMO Capital Markets | Investment Banking Pitch Book | 22 slides · BMO Capital Markets
Consulting deck Investment bank Beat · Evidence & ProofLoop · Pattern Hunter1 hit
10
The table compares initial and revised proposal premiums against a range of future P/NAV multiples to calculate potential IRR.BMO Capital Markets | Investment Banking Pitch Book | 22 slides · BMO Capital Markets
Consulting deck Investment bank Beat · Evidence & Proof1 hit
11
The slide uses a waterfall-style chart to compare valuation ranges across different methodologies, with a clear distinction between 'Core Methodologies' and 'Informational Purposes'.BMO Capital Markets | Investment Banking Pitch Book | 22 slides · BMO Capital Markets
Consulting deck Investment bank 1 hit